NHS Breast Screening - Support for management of Very High Risk (VHR) Women

NHS England has completed a procurement process titled "NHS Breast Screening - Support for management of Very High Risk (VHR) Women" within the health services industry category. This contract focuses on the continuation of services for a high-risk cohort of patients involved in the national Breast Screening Programme, to ensure service continuity as the service transitions to an in-house solution. The contract period runs from 1st April 2025 to 30th September 2026, with the procurement having been finalised on 6th March 2025.

The services will be provided across multiple locations, including the UK, British Overseas Territories, Channel Islands, Europe, Isle of Man, and other international regions. The procurement was conducted via a direct method, specifically a single tender action due to the below-threshold value of £30,152.25. This tender offers significant opportunities for businesses involved in health and medical services, particularly those experienced with high-risk patient management.

As the contract was awarded to THE CHRISTIE NHS FOUNDATION TRUST, it highlights the need for specialised expertise in handling complex patient care within the NHS framework. Companies with a strong track record in health services, particularly those who can offer seamless service transitions and continuity, would find this tender an excellent chance for business growth and to establish a partnership with NHS England. Additionally, this could be a beneficial opening for large enterprises within the health sector looking to expand their service offerings across diverse geographical locations.